Diagnostic Testing: Confirming the FCMD Diagnosis

The process of diagnosing Fukuyama Congenital Muscular Dystrophy (FCMD) involves a combination of clinical observation, specialized imaging, and precise genetic testing. Because FCMD affects the brain and eyes as well as the muscles, doctors use a multi-step approach to confirm the diagnosis and distinguish it from other forms of muscular dystrophy ^[1][2].

The Gold Standard: Genetic Testing

Genetic testing is the most definitive way to diagnose FCMD. It looks for mutations in the FKTN gene ^[3]. A diagnosis requires finding two disease-causing (pathogenic) variants. Finding only one variant, or variants of uncertain significance, does not by itself establish the diagnosis, and parental testing or RNA studies may be needed. However, standard genetic tests that only sequence the “coding” parts of genes (exons) may miss the most common causes of FCMD.

• The SVA Retrotransposon Insertion: In many Japanese patients, the cause is a specific “extra” piece of DNA, about 3,000 base pairs long, that has inserted itself into the gene ^[3]. This is known as the SVA founder mutation ^[4]. Because it is an “insertion” and not a typical spelling error in the gene code, specialized testing is often required to “see” it.
• The Deep-Intronic Variant: Some children carry one copy of the SVA insertion and a second mutation in a hidden area of the gene called an intron ^[5]. This specific mutation (known as c.647+2084G>T) tricks the body into including a “fake” piece of genetic code (pseudoexon) when making the fukutin protein, which prevents the protein from working ^[5][6].
• Zygosity: Your doctor will check if your child is homozygous (has two copies of the same SVA mutation) or compound heterozygous (has two different mutations in the FKTN gene) ^[3].

Imaging the Brain and Eyes

Because the FKTN gene is essential for how brain cells move during development, a Brain MRI is a useful tool for characterizing FCMD, though it is not required to confirm a genetically established diagnosis and may require sedation ^[2]. Note that MRI findings can vary from child to child.

• Cobblestone Lissencephaly: This is a hallmark of FCMD. During development, brain cells migrate too far, creating a bumpy, “cobblestone” appearance on the brain’s surface instead of the typical smooth folds ^[2][7].
• Cerebellar Cysts: Doctors often find small fluid-filled sacs (cysts) in the cerebellum, the part of the brain at the back that controls balance and coordination ^[2][8].
• White Matter Changes: The “white matter” (the brain’s wiring) often shows a brighter signal on MRI scans (T2-hyperintensity), which is more common in younger children or those with more severe symptoms ^[2][9].

Blood Biomarkers: Creatine Kinase (CK)

Creatine kinase (CK) is an enzyme found inside healthy muscle cells. When muscles are damaged or fragile, this enzyme leaks into the bloodstream ^[10].

• Elevated Levels: Children with FCMD typically have high CK levels, sometimes 10 to 50 times higher than normal ^[10].
• Interpretation: CK is nonspecific. It fluctuates with age, illness, activity, and muscle bulk. It does not reliably measure current strength or progression. While some studies have observed that CK levels may temporarily drop during a fever or infection, clinicians interpret CK in context, and a lower value during illness does not independently show improvement or guide treatment by itself ^[11].

Muscle Biopsy: Often Unnecessary

While genetic testing is now the preferred first step, a muscle biopsy (taking a tiny sample of muscle tissue) was historically routine. Today, a biopsy is often unnecessary when molecular testing is conclusive ^[1][12].

Under a microscope, scientists use special “stains” (antibodies) to see if the sugar coating is present on the alpha-dystroglycan protein. In FCMD, these stains will appear faint or be missing entirely. However, this hypoglycosylation is not specific to FKTN disease; it supports an alpha-dystroglycanopathy diagnosis but does not substitute for finding FKTN variants ^[5][13].

Summary Table: Diagnostic Indicators